摘要
目的 探讨细胞凋亡抑制基因bcl- 2 蛋白产物在喉癌中的表达及其临床意义。方法 应用免疫组化SABC方法检测41 例喉癌切除标本石蜡切片组织。结果 bcl- 2 蛋白在喉癌组织中有过度表达,其阳性表达率为512 % (24/41) ;bcl- 2 表达与喉癌病理组织学分级相关,肿瘤分化程度越高,bcl- 2 阳性表过率越高( P< 005) ,早期( Ⅰ、Ⅱ期) 喉癌中bcl- 2 表达明显高于晚期( Ⅲ、Ⅳ期)( P<005) ;bcl- 2 表达与肿瘤复发、转移无关P> 005) ;而与预后明显相关,bcl- 2 阳性组三年生存率明显高于阴性组P< 005) 。结论 bcl- 2 基因在喉癌中有异常表达,与喉癌的发生、发展相关。
Objective:In orderto study the expression of anti- apoptic gene bcl- 2 inlaryngealcarcinoma and its clinicalsignificance,41 cases oflaryngeal carcinoma were observed byimmunohistochemical SABCmethod . Methods:ImmunohistochemicalSABCwas used.Results: Overexpression of bcl- 2 protein could be deteded in la ryngealcarcinoma and its positive rate was 51 .2 % (21/41) . The expression of bcl- 2 protein was related with the degree of pathological differentiation oflaryngeal carcinoma:the hitherthe differentiation ,the higherthe expression ( P< 0 05) .Andthe expression of bcl- 2 in early stage ( Ⅰ,Ⅱ) was higherthan thatoflate stage ( Ⅲ,Ⅳ) ,but there was no difference betweenthe expressionin lymphatic metastatic group,recurrentgroup and non - metastatic or non- recurrent group(( P> 0 05) . Conclusion :bcl- 2 gene is abnomaly expressed in laryngeal carcinoma which suggestedit may plays animportantroleintherumorigenesis and developmentoflaryngealcarcinoma ,and bcl- 2 ex pression could be used as a good markerrelatingtothe prognosis oflaryngealcarcinoma .
出处
《泰山医学院学报》
CAS
1999年第3期262-263,共2页
Journal of Taishan Medical College